No details published, but Health Ministry source says no action now would mean waiting a year or more once vaccine is available

Report comes as countries scramble to ensure they will be among first to receive vaccines, if and when they become available; US biotech company to begin Phase 3 trials next month

Drugmaker to supply EU states with up to 400 million doses of desperately needed vaccine, as it scales up production with human trials still under way

US company says 'antibody cocktail' being tested on humans has ability to both prevent and treat infection

Bar Ilan researcher says she has laid the groundwork after researching coronavirus and identifying protein segments that could be replicated to build immunity

British pharma giant is partnering with Oxford University, which began trials with hundreds of volunteers in April, and is now expanding them to 10,000 participants

Researchers infect animals with the coronavirus to study their bodies' reaction, but say that much work still needs to be done

After German Jewish groups raise concerns, city introduces fine for those who use symbol meant to resemble the ones that Nazis forced Jews to wear during Holocaust

With over 100 labs scrambling to develop COVID-19 vaccination, pharma executives hopeful for roll out before 2021, but cite 'daunting' challenges in producing billions of doses

US biotech firm's shares soar as it claims progress in trials; analysts says sales, including by Israeli chief medical officer, are legal but undermine faith in company's future